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Hamilton, Ontario, Canada
Cardiovascular disease will likely become a major public health
and clinical problem in South Asia (India, Pakistan, Bangladesh,
Nepal). Estimates from the Global Burden of Disease Study
suggest that by the year 2020 India will have more individuals with
atherothrombotic cardiovascular disease than any other region (1).
Over the last 50 years, life expectancy in India has increased from
41 years between 1951 and 1961 to 61.4 years in the period 1991
to 1996. It is projected to reach 72 years by 2030. This change in
life expectancy is due to a substantial decline in both infectious
disease mortality and childhood deaths from perinatal causes.
Furthermore, with increasing rates of urbanization in India, major
changes in lifestyle patterns have occurred for a large proportion of
individuals. This has led to a trend toward decreasing physical
activity, increasing weight and, consequently, increasing rates of
diabetes, hypertension and dyslipidemia in urban populations. The
shift from a predominance of infectious diseases to a predomi-
nance of chronic diseases, such as cardiovascular disease or cancer,
is called the “epidemiological transition.”
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Various projections indicate that over the next 20 years the rates
of atherothrombotic cardiovascular disease will rise substantially in
developing countries, including India. These projections have at
least three limitations. First, there are few good national or
regional data available from many developing nations (including
those in the Indian subcontinent) that document the rates of
various cardiovascular diseases. Second, no large prospective co-
hort studies have been done in these regions that relate various risk
factors to cardiovascular disease. Third, data suggest that migrant
Indians have higher rates of cardiovascular disease compared to
indigenous populations (2). Therefore, South Asians may have
certain genetic or other risk factors that predispose them to higher
risks of atherothrombotic complications for the same level of risk
factors.
In this context, the Chennai Urban Population Study (CUPS),
discussed in this issue of the Journal (3), is welcomed. This is a
moderate-sized study done in a large South Indian city. The
sampling is primarily from a middle-class residential area and
should not be assumed to represent the prevalence of disease either
in the city of Chennai as a whole, in the state (Tamil Nadu) nor
in the country. Nevertheless, the study is a major step in providing
useful prevalence data and could potentially be the foundation for
future larger and longer-term studies. The key findings of CUPS
are the following. First, the rate of clearly documented ischemic
heart disease (Q-wave myocardial infarctions [MI] or clear history
of MI) is about 2.1%. An additional 8.5% had nonspecific changes
on the electrocardiogram (ECG), but these findings are difficult to
interpret given their nonspecificity, as well as the fact that T-wave
changes and ST-segment changes were unrelated to the usual risk
factors or age in this study. On univariate analyses, many of the
classical risk factors, such as a history of diabetes, hypertension,
dyslipidemia and others, were associated with the presence of
coronary artery disease (CAD) (using documented MI or
Q-waves on the ECG). However, marked differences in ages
existed between those with and without documented CAD, so
that on multivariate analyses only two risk factors (age and
elevated cholesterol) were statistically significant. These data
should not be interpreted as indicating that the classical risk factors
(such as tobacco use, diabetes or hypertension) are of no impor-
tance in this South Asian population. Instead, this is likely a
function of the very few events (under 50), such that the study had
low power to detect real associations (beta-error).
How do the CUPS data compare with other data among
South Asians? In India a few recent prevalence studies using
variable methodologies have been done over the last few years
(summarized by Gupta et al. [4]). The prevalence rates of
coronary heart disease varied from 7.6% to 12.6%, but the
criteria varied by study and many included ST-T changes,
which are nonspecific. However, compared to the prevalence
rates of clearly documented MI or Q-waves among migrant
Indians in the UK (4.2%) (5) or Canada (5.2%) (6), the rates in
Chennai, India, appear to be lower. Whether these differences
are due to small sample sizes, to differing age groups covered by
the studies, to the fact that the epidemiological transition has
not yet had its full impact among urban Indians compared to
those who have emigrated to the UK or North America, to
differences in risk factor levels or to other differences in study
design simply cannot be addressed at the moment.
Despite the useful information that the CUPS report provides,
one should recognize its limitations so that future studies can be
more informative. As stated earlier, the study is relatively small,
with only 1,000 individuals and ,50 cases of documented events
of MI or Q-waves on the ECG. Therefore, any analyses corre-
lating risk factors to disease prevalence is substantially underpow-
ered, and the failure to show a clear relationship with the classical
risk factors should not be interpreted as a lack of importance of
these factors among South Asians. Second, the study at present is
a prevalence study. The investigators intend to conduct a longi-
tudinal follow-up of these individuals, and useful data regarding
association of risk factors and disease should emerge in the future.
It is hoped that the investigators will also expand their study so as
to be substantially larger. Data from a case-control study in
Bangalore (from the adjacent state of Karnataka) suggest that
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some of the classical risk factors do indeed matter. For instance,
Pais et al. (7) discovered that tobacco use (both cigarettes and
“beedies,” an indigenous form of smoking) is significantly associ-
ated with the risk of MI. In addition, this study showed a clear
relationship among hypertension, diabetes and elevation of glu-
cose levels, even within normal range, with MI. In particular,
abdominal obesity (but not overall body mass index) was clearly
related to disease. These data reflect similar experiences by other
investigators such as McKeigue et al. (8).
Given that cardiovascular disease is already a major problem
in India and is likely to be substantially more common in the
future, much larger prevalence and cohort studies involving
50,000 to 100,000 individuals should be considered. Ideally,
these studies should be geographically representative, as Indi-
ans in different parts of the country have both diverse lifestyles
(diet, physical activity, among others) and social structures.
Therefore, one would expect marked variations in risk-factor
levels. Furthermore, there also appear to be marked urban and
rural differences in both lifestyle and risk factors (9,10). An
initial prevalence study involving a number of regions across
the country, with long-term follow-up of these individuals for
at least 10 years, will provide much needed data on the
relationship between traditional and novel risk factors with the
development of clinical disease. Several investigators in India
are either conducting or are currently planning prevalence
studies with the intention of following the individuals long
term. Collaboration among these investigators would enable
standardization of data collection across the studies. This
would enable the results to be compared or even combined; this
would make a substantial impact that would be of great value
for several countries in the region.
Other important sources of data are registries for the manage-
ment of common conditions. Clinical investigators should join
together to develop simple registries to assess compliance with
evidence-based guidelines, associated outcomes and complications
of current patterns of practice. Registries have already been
established in a limited number of centers for unstable angina (the
OASIS Registry involves about 1,000 patients; unpublished data)
and MI (11). A large national registry in acute coronary syn-
dromes (the CREATE Registry) is currently underway. This
registry aims to involve over 100 centers representing various
regions of the country. Establishment of national registries would
also be useful for stroke, heart failure, atrial fibrillation or valvular
heart disease.
Finally, with the leadership of key scientists, national soci-
eties such as the Association of Physicians of India, the
Cardiological Society of India, the Indian Council of Medical
Research and the state and national governments, a broad and
sustainable strategy for cardiovascular research and prevention
should be developed. Such a strategy should recognize the
unique societal influences, regional cultural diversity and the
changing lifestyles as rates of urbanization continue to increase
dramatically. Emphasis on prevention in the education of
medical graduates will facilitate the involvement of the medical
community in prevention efforts. Strong methods to control
the use of and exposure to tobacco, coupled with promotion of
healthy lifestyles, such as increased physical activity and de-
creased fat and carbohydrate consumption, should be an
integral part of any national program. A comprehensive strat-
egy should be designed so that all stages of the life cycle are
targeted, including young children in schools and the prenatal
period.
Globally, there is a realization that cardiovascular disease
will soon overtake infectious diseases as the major cause of
mortality and morbidity in low-income and middle-income
countries. Consequently, the Global Forum of Health Re-
search has established the Cardiovascular Disease in Develop-
ing Countries Initiative, with its secretariat based in Delhi,
India. It is essential that this well-intentioned and very impor-
tant effort is strongly supported by leading international agen-
cies such as the World Health Organization, the World Heart
Federation and the World Bank to ensure success. Collabora-
tive efforts among active researchers located in several parts of
India and other developing and developed countries could form
the infrastructure for an international network dedicated to the
prevention of cardiovascular disease (12).
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